BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Honda K, Seike M, Oribe J, Endo M, Arakawa M, Syo H, Iwao M, Tokoro M, Nishimura J, Mori T, Yamashita T, Fukuchi S, Muro T, Murakami K. Risk factors for deterioration of long-term liver function after radiofrequency ablation therapy. World J Hepatol 2016; 8(13): 597-604 [PMID: 27168872 DOI: 10.4254/wjh.v8.i13.597]
URL: https://www.wjgnet.com/1948-5182/full/v8/i13/597.htm
Number Citing Articles
1
Li Geng, Ruilong Zong, Yibing Shi, Kai Xu. Prognostic role of preoperative albumin-bilirubin grade on patients with hepatocellular carcinoma after surgical resection: a systematic review and meta-analysisEuropean Journal of Gastroenterology & Hepatology 2020; 32(7): 769 doi: 10.1097/MEG.0000000000001618
2
Hajime Matsushima, Yuko Takami, Tomoki Ryu, Munehiro Yoshitomi, Masaki Tateishi, Yoshiyuki Wada, Hideki Saitsu. Prognosis of Hepatocellular Carcinoma Patients Who Achieved Long-Term Recurrence-Free Survival After Curative Therapy: Impact of the ALBI GradeJournal of Gastrointestinal Surgery 2018; 22(7): 1230 doi: 10.1007/s11605-018-3745-6
3
Toru Wakamatsu, Sadahisa Ogasawara, Tetsuhiro Chiba, Masayuki Yokoyama, Masanori Inoue, Naoya Kanogawa, Tomoko Saito, Eiichiro Suzuki, Yoshihiko Ooka, Akinobu Tawada, Osamu Yokosuka, Gianfranco D. Alpini. Impact of Radiofrequency Ablation-Induced Glisson’s Capsule-Associated Complications in Patients with Hepatocellular CarcinomaPLOS ONE 2017; 12(1): e0170153 doi: 10.1371/journal.pone.0170153